☰

Empresas y finanzas

Elsevier Health Sciences CEO Brian Nairn to Retire; Michael Hansen, Former CEO of Harcourt Assessment to Succeed


    Elsevier (NYSE:RUK) (NYSE:ENL) (Amsterdam:REN) (LSE:REL), the leading

    publisher of scientific, technical and medical information, announced

    today that Brian Nairn, CEO of Elsevier Health Sciences, is retiring

    from the company. Michael Hansen, the former CEO of Harcourt Assessment

    Inc., has been appointed to succeed Nairn and will report to Erik

    Engstrom, Elsevier´s CEO; effective June 9th.

    Nairn will remain with the company during a transition period.
    Erik Engstrom said of Brian´s retirement, "I

    would like to thank Brian for his dedication to the company during his

    eight years as CEO of Elsevier Health Sciences. In this time the

    division has more than doubled in revenue, has consistently outperformed

    the competition and is executing on an exciting segment-based growth

    strategy."
    Michael Hansen brings extremely relevant experience to his new role. He

    recently served as CEO of Harcourt Assessment formerly owned by Reed

    Elsevier. He was previously with Bertelsmann, as EVP of Operational

    Excellence. He started his career at The Boston Consulting Group in New

    York, where he became a Partner and Chairman of the global Media

    Convergence practice and was a senior member of the firm´s

    health care practice.
    Michael said of the appointment, "I´m

    very proud to join a company that is so uniquely positioned to improve

    the quality and performance of healthcare delivery worldwide. Brian has

    developed a powerful team that is driving a rapid growth program in

    Elsevier Health Sciences. I am very much looking forward to working with

    them to build on this record of success."
    Hansen holds a law degree from the University of Bonn in Germany and an

    MBA from Columbia University in New York.
    ###
    About Elsevier
    Elsevier is a world-leading publisher of scientific, technical and

    medical information products and services. Working in partnership with

    the global science and health communities, Elsevier´s

    7,000 employees in over 70 offices worldwide publish more than 2,000

    journals and 1,900 new books per year, in addition to offering a suite

    of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/)

    MD Consult (http://www.mdconsult.com/)

    Scopus (http://www.info.scopus.com/)

    bibliographic databases, and online reference works.
    Elsevier (http://www.elsevier.com/)

    is a global business headquartered in Amsterdam, The Netherlands and has

    offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/)

    a world-leading publisher and information provider. Operating in the

    science and medical, legal, education and business-to-business sectors

    Reed Elsevier provides high-quality and flexible information solutions

    to users, with increasing emphasis on the Internet as a means of

    delivery. Reed Elsevier´s ticker symbols are REN (Euronext Amsterdam)

    REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).